Definitive Contract 75F40119C10136
Award Date 9/20/19
Potential Completion Date 9/22/25
Potential Value $2.2M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Washington, DC 20052, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,541,575.52 definitive contract awarded by the Food and Drug Administration (FDA) to The George Washington University's Student Accounts Office / Third Party Division. The contract is for the "Community Based Development of NGS Standards for Validating Data and Computation and Encouraging Interoperability" and does not have a set-aside designation. The contract was awarded on September 9, 2015 and has an ultimate completion date of September 29, 2020. The George...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $85,391 firm-fixed-price purchase order to The George Washington University Student Accounts Office/Third Party Division to support the "ADVANCING FETAL PHARMACOLOGY THROUGH REGULATORY SCIENCE? (PERINATAL HEALTH CENTER OF EXCELLENCE -PHCE AWARD" project. The contract, which does not have a set-aside designation, is scheduled for completion on September 9, 2023. As a private university and...
- This is a federal contract award to George Washington University (The) Student Accounts Office / Third Party Division, a private university located in Washington, D.C. The contract, which is not set aside, is a definitive, cost-no-fee contract with a potential value of $21,550,000.00. It was awarded on November 15, 1995 with a completion date of June 30, 2008. As the prime contractor, George Washington University (The) Student Accounts Office / Third Party Division has provided a variety of...
- The U.S. Department of Defense's Defense Health Agency awarded a firm-fixed-price definitive contract to George Washington University (The) for MEP pathway inhibitor synthesis services. The $341,842.29 contract has an ultimate completion date of August 25, 2025. George Washington University (The)'s Student Accounts Office / Third Party Division is the prime contractor, and there is no set-aside designation for this award. The contract aims to support the agency's medical research efforts through...
- This is a $190,971.00 firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to The George Washington University Student Accounts Office / Third Party Division. The contract is for biostatistician support services with a performance period ending on March 31, 2025. The contract does not have a set-aside designation. The George Washington University has an established history of providing training, research, and other services to various federal...
- This is a contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Guidehouse LLP, doing business as PricewaterhouseCoopers Public Sector. The contract is for the FDA Budget System Improvement Project, which involves upgrading Microsoft servers. The contract is a Blanket Purchase Agreement (BPA) Call under the General Services Administration (GSA) IT Schedule 70 contract vehicle, with a pricing type of Labor Hours. The total potential value of the...
- The U.S. Food and Drug Administration (FDA) awarded a Firm Fixed Price Definitive Contract worth $386,781.00 to Johannes Gutenberg-Universitat Mainz, also doing business as UNI Mainz, a state-controlled institution of higher learning. The contract is for a Broad Agency Announcement (BAA) to "Improve Scientific Approaches to Evaluate Generic Drugs". The contract has an ultimate completion date of June 30, 2025 and was awarded on July 27, 2021. No set-aside was used for this award.
- This is a $22,675.00 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to George Washington University's Student Accounts Office / Third Party Division. The contract is for isolating, processing, freezing/storing, and shipping up to 100 samples of 16 mL of peripheral blood mononuclear cells over a period of up to 12 months, with a completion date of August 31, 2025. The contract does not have a set-aside designation....
- This is a $978,324 definitive contract awarded by the Food and Drug Administration (FDA) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for a 2-year period ending in April 2025. The contract is to enhance the FDA's Source Model by incorporating and analyzing state and regional-level data. The contract was awarded under a Broad Agency Announcement (BAA) that solicits advanced research and development proposals to support FDA regulatory science...
- This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to Georgia Tech Research Corporation, a non-profit research organization and state institution of higher education. The contract, valued at $1,470,387.82, is for the identification of critical quality attributes of cell therapy products through multi-omics analyses and predictive modeling. The contract was awarded on September 30, 2020 and has a completion date of September 29, 2024....